Treatment Adherence and Adherence Patterns of Tofacitinib and Self‐Injectable TNFi Use in People with Rheumatoid Arthritis
Objective To assess tofacitinib and self‐injectable tumor necrosis factor inhibitor (TNFi) adherence using the Medication Event Monitoring System (MEMS) and characterize association with adherence in patients with rheumatoid arthritis (RA). Methods Eligible patients were enrolled from the Forward Da...
Main Authors: | Kaleb Michaud, Sofia Pedro, Eric Tousset, Rebecca Schumacher, Ekta Agarwal, Bernard Vrijens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11622 |
Similar Items
-
Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis
by: Kaleb Michaud, et al.
Published: (2019-11-01) -
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
by: Sarah Brown, et al.
Published: (2018-06-01) -
Use of YAKVINUS® (tofacitinib) for the treatment of rheumatoid arthritis
by: article Editorial
Published: (2018-06-01) -
THE PLACE OF TOFACITINIB IN THE TREATMENT STRATEGY OF RHEUMATOID ARTHRITIS
by: V. I. Mazurov, et al.
Published: (2018-05-01) -
NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)